Brooklyn, New York, USA, 2021-June-16 — /Meridian Market Consultants/ — The report is titled ‘Biopsy Devices Market Size, Shares, Insights and Forecast Report – 2028’. An overview of conceptual frameworks, analytical approaches of the Biopsy Devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The Biopsy Devices market is expected to grow at a significant rate in the near future.

The global Biopsy Devices market was valued US$ 34.1 Bn at the end of 2020 and expected to reach at a value of US$ 53.1 Bn by 2028 with a significant CAGR of 5.7%.




Get PDF Sample Copy of the Report including Full TOC, List of Tables & Figures, Chart: https://meridianmarketconsultants.com/sample-request/1131




Biopsy Devices Market Dynamics

The growing incidence of cancer is the foremost factor driving the growth of the global biopsy devices market. According to Cancer Research U.K., 357,000 new cases of cancer were diagnosed in the U.K. in 2014, and the incidence rate is expected to increase by 2% every year by 2035. This growth in incidence clearly indicates the rising demand for biopsy devices in the nearest future. The market for biopsy devices is expected to witness a rapid rise due to a growing number of hospitals and diagnostic centers in emerging markets of the Asia Pacific and Latin America. The global biopsy devices market report includes market estimates and trends by device types, indication, and geography.

Besides, the growing demand for minimally invasive procedures is expected to expand the need for biopsy devices in hospitals and diagnostic centers over the forecast period of 2019-2027. According to Eurostat surgical operation and procedures statistics, the biopsy is the second most common diagnostic procedure for cancer diagnostics in Europe.

Ask for Customization: https://meridianmarketconsultants.com/free-customization/1131

Biopsy Devices Market Segmentation

The global biopsy devices market is segmented on the basis of devices, indication, and region. On the basis of devices, the global biopsy devices market can be segmented into breast biopsy devices, Core needle biopsy devices, fine needle aspiration biopsy devices, gastrointestinal biopsy devices, and robotic guidance systems. On the basis of indication, the global biopsy devices market can be segmented into breast cancer, gastrointestinal cancer, cervical cancer, lung cancer, and others.

The global biopsy devices market is expected to increase at a steady CAGR over the forecast period owing to the increasing chronic diseases, geriatric population, and increase in trend for immediate relief across the healthcare receivers.



Biopsy Devices Market Key Players

The biopsy devices market is mainly dominated by C. R. Bard Inc., Becton, Dickinson and Company, INRAD Inc., Cook Group Incorporated, B. Braun Melsungen AG, Boston Scientific Corporation, Medtronic Inc., Devicor Medical Products, Inc., and Hologic Inc.




To Identify the Key Trends in the Global Industry, Visit: https://meridianmarketconsultants.com/global-biopsy-devices-market

About Meridian Market Consultants:

Meridian Market Consultants (MMC) is committed to providing deep insights that serve as a creative tool for the client that enables it to perform confidently in the market. At MMC we adhere to the client's needs and regularly ponder to bring out more valuable and real outcomes for our customers. We are equipped with a strategically enhanced group of researchers and analysts that redefines and stabilizes the business polarity in different categorical dimensions of the market.

Contact Us:

Meridian Market Consultants (MMC)

1820 Avenue M,

Brooklyn, NY 11230

United States

Tel: +1-(281)-619-8646

Effects due to the COVID-19 Pandemic on Global Markets: Meridian Market Consultants | COVID-19 PANDEMIC & MARKET